Robin, Marie http://orcid.org/0000-0003-1388-9876
Porcher, Raphael http://orcid.org/0000-0002-5277-4679
Orvain, Corentin
Bay, Jacques-Olivier
Barraco, Fiorenza
Huynh, Anne
Charbonnier, Amandine
Forcade, Edouard http://orcid.org/0000-0002-8873-2868
Chantepie, Sylvain
Bulabois, Claude
Yakoub-Agha, Ibrahim http://orcid.org/0000-0003-4524-8782
Detrait, Marie
Michonneau, David http://orcid.org/0000-0003-4553-3065
Turlure, Pascal
Raus, Nicole
Boyer, Françoise
Suarez, Felipe
Vincent, Laure http://orcid.org/0000-0001-5904-1286
Guyen, Stéphanie N.
Cornillon, Jérôme
Villate, Alban
Dupriez, Brigitte
Cassinat, Bruno
Rolland, Valérie
Schlageter, Marie Hélène
Socié, Gérard http://orcid.org/0000-0002-2114-7533
Kiladjian, Jean-Jacques
Article History
Received: 4 December 2020
Revised: 28 January 2021
Accepted: 19 February 2021
First Online: 25 March 2021
Compliance with ethical standards
:
: This trial has received financial support from Novartis. BD: Advisory board Novartis; EF: Advisory board Novartis; DM: Speaker bureau for Novartis and Incyte; GS: Speaker bureau Novartis, Incyte, Elsalys, Consultant Alexion; IYA: honorarium and advisory board Novartis; JJK: consultant for Novartis, Celgene, and AOP Orphan; received research funding from Novartis. MD: research funding by Novartis and Jazzpharma MR: research funding by Novartis, Neovii; speaker bureau for Novartis and Incyte
Free to read: This content has been made available to all.